|

VAX014 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Vaxiion Therapeutics1

Indications

  • Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab1
  • Advanced Solid Tumor1
  • Cancer1

Tucson, Arizona1 trial

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

University of Arizona Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.